β³ Fetching live dividend data...
Home βΊ Calculator βΊ INIS Dividend Calculator 2026
Radnostix, Inc. Β· OTC
Price: $0.05 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in INIS β $993872422991.24M in 10 years Β· $76,805,578,757,877,550.00/month
Radnostix, Inc. (INIS) is a company that specializes in the global manufacturing and sale of crucial nuclear medicine calibration and reference standards, cobalt-60 products, and offers contract services for producing radiopharmaceuticals and radiochemicals. Its operations are structured into five key divisions: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment is responsible for creating various sources and standards essential for single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging, accurate patient positioning, and for calibrating or testing the performance of dose-measuring equipment within the nuclear pharmacy industry. This segment's product range includes flood sources, dose calibrators, rod sources, flexible and rigid rulers, precision spot and pen point markers, and numerous custom-designed items. The Cobalt Products division processes bulk cobalt, fabricates cobalt capsules for use in radiation therapy and diverse industrial applications, and is involved in the recycling of depleted cobalt sources. Through its Radiochemical Products segment, Radnostix develops and supplies a variety of highly pure radiochemicals, along with the generic drug product sodium iodide I-131, serving medical, industrial, and research applications. The Radiological Services segment offers specialized services such as the safe disposal of flood sources and the intricate processing of gemstones. Finally, the Fluorine Products segment focuses on producing small-scale, high-purity fluoride gas samples for qualification in various industrial applications. It also undertakes the development of critical laboratory and analytical processes required to support a planned uranium de-conversion and fluorine extraction facility. Radnostix, Inc. distributes its products directly to end-users as well as through a network of distributors. The company was founded in 1995 and is headquartered in Idaho Falls, Idaho.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open INIS position with:
Real after-tax yield depends on where you live and how you hold INIS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 4000.00% | 3997.20% | $400,000 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 3400.00% | 3397.20% | $340,000 / yr |
| πΊπΈ US Taxable (20%) | 20% | 3200.00% | 3197.20% | $320,000 / yr |
| π¬π§ UK ISA | 0% | 4000.00% | 3997.20% | $400,000 / yr |
| π¬π§ UK Taxable | 8.75% | 3650.00% | 3647.20% | $365,000 / yr |
| π¨π¦ TFSA | 0% | 4000.00% | 3997.20% | $400,000 / yr |
| π¨π¦ CA Taxable | 25% | 3000.00% | 2997.20% | $300,000 / yr |
| π¦πΊ Super (pension) | 15% | 3400.00% | 3397.20% | $340,000 / yr |
| π¦πΊ AU Taxable | 30% | 2800.00% | 2797.20% | $280,000 / yr |
| π©πͺ DE Taxable | 26.375% | 2945.00% | 2942.20% | $294,500 / yr |
| π«π· FR Taxable | 30% | 2800.00% | 2797.20% | $280,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
INIS pays quarterly β 4 times per year. Next ex-div: TBD.
How INIS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for INIS sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| J-Other | 2025-02-17 | 269,999 | β | β | ||
| J-Other | 2025-02-17 | 230,769 | β | β | ||
| J-Other | 2025-02-17 | 40,384 | β | β | ||
| A-Award | 2025-10-10 | 250,000 | β | β | ||
| A-Award | 2025-10-10 | 500,000 | $0.06 | $30.0K | ||
| A-Award | 2025-10-10 | 500,000 | $0.06 | $30.0K | ||
| A-Award | 2025-10-09 | 37,500,000 | β | β | ||
| Buy | 2025-05-22 | 140,000 | $0.05 | $7.0K | ||
| A-Award | 2024-10-30 | 1,500,000 | $0.04 | $52.5K | ||
| J-Other | 2024-02-17 | 280,800 | β | β |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the INIS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Radnostix, Inc. (INIS) is currently trading at $0.05, 64% below its 52-week high. The current dividend yield is 4000.00% based on an annual payout of $2.00 per share.
Radnostix, Inc. (INIS) is a healthcare stock currently trading at $0.05 with a dividend yield of 4000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β